ReWalk Announces 510k FDA Submission for ReStore(TM) Exo-Suit for Stroke Rehabilitation

Stock Information for ReWalk Robotics Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ReWalk Robotics Ltd.

ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
ReWalk Robotics Expands Direct Sales Coverage to Canada
ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17
First ReWalk Personal Exoskeleton Claim Paid by Medicare
ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities
ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting
ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype
ReWalk Robotics Reports Third Quarter 2023 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.